Aversive Therapy for Smoking Cessation

July 14, 2021 updated by: Nipam Shah, MD, University of Alabama at Birmingham

Acceptability and Feasibility of Self Administered Aversive Therapy for Smoking Cessation

The purpose of this research study is to test a new way to help people quit smoking. The PI will test acceptability and feasibility of a new device called Pavlok wearable wrist band. Participants will be smokers who are highly motivated to quit. Participants will be randomized into intervention and control groups.

Study Overview

Detailed Description

The participants will be evaluated after 1 week and assessed for their ongoing participation and commitment to the study. Those still interested and eligible will be randomized to two groups described below and will continue the study for 3 more weeks. There will be follow up surveys at various time points while wearing the wristband (1 week, 2 week, 3 weeks) and a final survey at T=3 months.

The intervention group will continue to wear the wristband and the wristband will deliver a slight electric stimulus every time it is pressed.

The placebo group will wear continue to press the button on the wristband but it will not give a slight electric stimulus when pressed. Both groups will wear the device for a total of 4 weeks.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • Univeristy of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Current smoker (defined by the Center for Disease Control as an "adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes cigarettes ". This will be determined based on participant baseline survey.
  • Interested in quitting (contemplation stage and beyond, as defined by serious consideration of quitting smoking in the next 30 days
  • Subject is equal to or greater than 19 years old
  • Considers themselves "tech savvy" (based on self reported 5 point likert scale)
  • Must have a smart phone with blue tooth capabilities
  • Willing to receive aversive therapy if assigned to this group.

Exclusion Criteria:

  • Anyone with a diagnosed arrhythmia or with a pacemaker or with a phobia or history of psychosis.
  • Non-English speaking caregivers
  • Lives outside of contiguous United States

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pavlok wristband with electric stimulus
Participants in intervention group will wear wristband and will get a slight electric stimulus when they press the device
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Device has maximum voltage of 0-500 volts, delivers a electric stimulus for a maximum of 1 sec and average duration of 0.2 secs
Placebo Comparator: Pavlok wristband without electric stimulus
Participants in control group will wear wristband and will not get a slight electric stimulus when they press the device
it is a device for various behavior modifications in the form of wristband which participants will wear on the wrist. Participants will not receive any electric stimulus since this feature will be turned off.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participants acceptability: short customized survey
Time Frame: T=0 to 3 months
Participants' acceptability/satisfaction will be assessed using a short customized survey. The survey will include 8 questions with options ranging from strongly agree to strongly disagree for five questions and ranging from satisfaction to dissatisfaction for the remainder 3 questions. Each question will be evaluated individually.
T=0 to 3 months
Evaluate the dropout among participants
Time Frame: T=0 to 3 months
Number of participants dropped out from time of randomization. Dropout is defined as missing two follow up assessments.
T=0 to 3 months
Enrollment percentage of eligible participants
Time Frame: Baseline to T=0
PI will evaluate the percentage of participants that were enrolled after the 1 week run in period.
Baseline to T=0
Percentage of time wristband worn by participants
Time Frame: T=0 to one week
PI will evaluate the percentage of time the wristband is worn. Instructions will be given to wear the wristband all of the waking hours.
T=0 to one week
Percentage of time wristband worn by participants
Time Frame: from one week to two weeks
PI will evaluate the percentage of time the wristband is worn. Instructions will be given to wear the wristband all of the waking hours.
from one week to two weeks
Percentage of time wristband worn by participants
Time Frame: from two week to three weeks
PI will evaluate the percentage of time the wristband is worn. Instructions will be given to wear the wristband all of the waking hours.
from two week to three weeks
Participants satisfaction: short customized survey
Time Frame: T=0 to 3 months
Participants' acceptability/satisfaction will be assessed using a short customized survey. The survey will be a Likert scale and will include 2 questions with options ranging from satisfied to dissatisfied (with 1 indicating satisfaction and 5 indicating dissatisfaction). One other question is a likert scale with options ranging from 1-3 with 1 indicating the device was very useful and 3 indicating the device was not at all useful. A higher score indicates a worse outcome (less satisfaction with the device). Each question will be evaluated individually.
T=0 to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of participants that made a quit attempt
Time Frame: From T=0 to one week
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days. This will be assessed through the follow up survey given at various intervals.
From T=0 to one week
Percentage of participants that made a quit attempt
Time Frame: From T=1 week to 2 weeks
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days. This will be assessed through the follow up survey given at various intervals.
From T=1 week to 2 weeks
Percentage of participants that made a quit attempt
Time Frame: From T= 2 weeks to 3 weeks
PI will evaluate the percentage of participants that made a quit attempt as defined by absence of smoking for more than 24 hours in the previous seven days. This will be assessed through the follow up survey given at various intervals.
From T= 2 weeks to 3 weeks
Average Degree of smoking reduction
Time Frame: From baseline to 3 months
PI will evaluate the average percentage of smoking reduction. This will be quantified by the average number of cigarettes smoked at baseline compared to the average number of cigarettes smoked at 3 months. This will be assessed via the "Follow survey".
From baseline to 3 months
Percentage of participants who had cessation of smoking.
Time Frame: T=0 to T= 3 weeks
P will evaluate the percentage of participants who had cessation of smoking, as defined by the absence of smoking in the previous 30 days. This will be evaluated by the "Three month Questionnaire"
T=0 to T= 3 weeks
Before and after smoking self-efficacy score
Time Frame: Baseline to 3 months
The PI will evaluate the self-efficacy of the participant as evaluated by the "Baseline Smoking self-efficacy scale Short form". There are 9 questions which will assess the confidence of the participant to not smoke.The investigators will use Likert scale for each question which assesses the participants confidence to "not smoke" in various circumstances. The answers range from 1 to 5 with 1 indicating "not at all confident" and 5 indicating "extremely confident". The overall score for each participant will be calculated by sum of scores from all items. This score for individual subscales will be calculated by sum item scores so that the total score will range from 9 to 45, with a lower score indicating a worse outcome i.e. less confidence to not smoke).
Baseline to 3 months
Stage of change
Time Frame: From baseline until 3 months
The investigators will use Likert scale for each question to evaluate the motivation to change. A score of 1 indicates that the participant has no intention to quit smoking and the score of 5 indicates that the participant is highly motivated. Evaluate the initial stage of change of the participant as judged by "Screening Questionnaire, Stage of Change". There is only 1 question.
From baseline until 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura Rochford, MD, University of Alabama at Birmingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 20, 2018

Primary Completion (Actual)

November 30, 2020

Study Completion (Actual)

May 1, 2021

Study Registration Dates

First Submitted

February 13, 2018

First Submitted That Met QC Criteria

February 22, 2018

First Posted (Actual)

March 1, 2018

Study Record Updates

Last Update Posted (Actual)

July 15, 2021

Last Update Submitted That Met QC Criteria

July 14, 2021

Last Verified

September 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • F23234543

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Pavlok wristband with electric stimulus

3
Subscribe